Lawrence S. Zachary, M.D. from the University of Chicago presents on Fat Transfer to the upper and lower extremities in patients with Raynaud's Phenomenon.
The utility of assessing gene expression in skin to evaluate treatment response: What becomes of all those skin biopsies? is presented by
Monique Hinchcliff MD, MS
Northwestern Scleroderma Program
Healthy Diet and Scleroderma
Bethany Doerfler MS, RD, LDN
Presented at the Scleroderma Patient Education Conference, Saturday, October 19, 2013 at Northwestern Memorial Hospital.
Hosted by the Scleroderma Foundation, Greater Chicago Chapter and the Northwestern Scleroderma Program.
RESEARCH UPDATE: GENE EXPRESSION IN SSC
Monique Hinchcliff MD, MS
Presented at the Scleroderma Patient Education Conference, Saturday, October 19, 2013 at Northwestern Memorial Hospital.
Hosted by the Scleroderma Foundation, Greater Chicago Chapter and the Northwestern Scleroderma Program.
Pulmonary Arterial Hypertension Overview
Michael J. Cuttica MD Assistant Professor of Medicine Northwestern Pulmonary Hypertension Program
Northwestern University
Ammie Peters, a life coach from Blessings 2 Good, shares her story. After being diagnosed with a rare blood disease in 1992 and exhausting all treatment options, she almost lost hope, but was able to get healthier, lead a productive life and now encourages other patients to stay positive and never give up hope.
Lawrence S. Zachary, M.D. from the University of Chicago presents on Fat Transfer to the upper and lower extremities in patients with Raynaud's Phenomenon.
The utility of assessing gene expression in skin to evaluate treatment response: What becomes of all those skin biopsies? is presented by
Monique Hinchcliff MD, MS
Northwestern Scleroderma Program
Healthy Diet and Scleroderma
Bethany Doerfler MS, RD, LDN
Presented at the Scleroderma Patient Education Conference, Saturday, October 19, 2013 at Northwestern Memorial Hospital.
Hosted by the Scleroderma Foundation, Greater Chicago Chapter and the Northwestern Scleroderma Program.
RESEARCH UPDATE: GENE EXPRESSION IN SSC
Monique Hinchcliff MD, MS
Presented at the Scleroderma Patient Education Conference, Saturday, October 19, 2013 at Northwestern Memorial Hospital.
Hosted by the Scleroderma Foundation, Greater Chicago Chapter and the Northwestern Scleroderma Program.
Pulmonary Arterial Hypertension Overview
Michael J. Cuttica MD Assistant Professor of Medicine Northwestern Pulmonary Hypertension Program
Northwestern University
Ammie Peters, a life coach from Blessings 2 Good, shares her story. After being diagnosed with a rare blood disease in 1992 and exhausting all treatment options, she almost lost hope, but was able to get healthier, lead a productive life and now encourages other patients to stay positive and never give up hope.
Scleroderma Associated Lung Disease is presented by
Jane Dematte MD, MBA, Director, ILD program
Division of Pulmonary and Critical Care, Northwestern Feinberg School of Medicine
Dr. Dean Schraufnagel from the University of Illinois at Chicago presented information about ILD at a Scleroderma Patient Education Conference on Saturday, March 15, 2014 which was hosted by the Scleroderma Foundation, Greater Chicago Chapter.
Bethany Doerfler MS, RD, LDN discusses top nutrition concerns of scleroderma patients, as well as the results of a recent medical nutrition therapy study. She also discusses strategies for healthy eating, combating GI issues, maintaining muscle, a Mediterranean diet, supplements and more.
Erectile Dysfuncation and Scleroderma is presented by
N. Bennett, MD, FACS
Associate Professor of Urology, Department of Urology, Northwestern University, Feinberg School of Medicine
Co-Director Andrology Fellowship
What Should I Eat includes information and answers to patient questions regarding diet, nutrition and scleroderma. It is presented by Bethany Doerfler, MS, RD, LDN
A patient's inspiring journey and practical tips that are applicable to everyone. Learn how to strengthen certain parts of your body as well as modify exercises to maintain physical health while coping with scleroderma.
Sleep is significantly disturbed for various reasons in chronic illnesses. Treating the sleep disturbance concomitantly with the underlying illness may lead to improved quality of life.
Sleep, depression and pain are interdependent symptoms. Hrayr Attarian, MD discusses sleep in chronic illnesses with a focus on scleroderma.
Benjamin Korman, MD discusses the genetics of scleroderma and the genomic era. Genetics and genomics are complicated, and getting more so every day. Every patient is genetically unique, but new technology will make it easier to understand individuals’ genetic susceptibility to disease and response to therapy.
Darren M. Brenner, MD, Assistant Professor of Medicine and Surgery at Northwestern University's Feinberg School of Medicine discusses fecal incontinence in scleroderma patients including its prevalence, diagnostics, types and therapeutics.
Benefits of Physical Therapy for Patients with Scleroderma is presented by
Jessica Mandac, PT, DPT
Rehabilitation Institute of Chicago
Center for Pain Management
The Rehabilitation Institute of Chicago's Karen Grube presents on the effects of Physical Therapy on Scleroderma. Find out what the current research tells us about PT and Scleroderma and what kind of problems PT can help.
Michael J. Cuttica MD, Assistant Professor of Medicine at the Northwestern Pulmonary Hypertension Program of Northwestern University discusses Pulmonary Arterial Hypertension in scleroderma patients, including how it is diagnosed and treated.
Skin Complications in Scleroderma
Emily L Keimig, MS, MD Clinical Instructor Department of Dermatology
Presented at the Scleroderma Patient Education Conference, Saturday, October 19, 2013 at Northwestern Memorial Hospital.
Hosted by the Scleroderma Foundation, Greater Chicago Chapter and the Northwestern Scleroderma Program.
Pulmonary Arterial Hypertension: The Other High Blood Pressure and its association with scleroderma is presented by
Micheal J. Cuttica MD, MS, Assistant Professor of Medicine, Director; Northwestern Pulmonary Hypertension Program, Northwestern University
Dr. Roberto Machado from the University of Illinois at Chicago presented an update on PAH at a Patient Education Conference on March 15, 2014 hosted by the Scleroderma Foundation, Greater Chicago Chapter.
The Role of Extracorporeal Photopheresis in Scleroderma is presented by
Jaehyuk Choi
Assistant Professor in the Department of Dermatology
Director of the Extracorporeal Photopherisis Unit
SCLERODERMA: Searching for the Cause and the Cure
Maureen D. Mayes, MD, MPH Professor of Medicine Director of the Scleroderma Program Division of Rheumatology University of Texas - Houston
Presented at the Scleroderma Patient Education Conference, Saturday, October 19, 2013 at Northwestern Memorial Hospital.
Hosted by the Scleroderma Foundation, Greater Chicago Chapter and the Northwestern Scleroderma Program.
Renal Denervation in Resistant Hypertension 23.pptxPrerna806536
Device based therapy for management of resistant hypertension includes many modalities, out of which Renal Artery denervation is very close to clinical application.
Scleroderma Associated Lung Disease is presented by
Jane Dematte MD, MBA, Director, ILD program
Division of Pulmonary and Critical Care, Northwestern Feinberg School of Medicine
Dr. Dean Schraufnagel from the University of Illinois at Chicago presented information about ILD at a Scleroderma Patient Education Conference on Saturday, March 15, 2014 which was hosted by the Scleroderma Foundation, Greater Chicago Chapter.
Bethany Doerfler MS, RD, LDN discusses top nutrition concerns of scleroderma patients, as well as the results of a recent medical nutrition therapy study. She also discusses strategies for healthy eating, combating GI issues, maintaining muscle, a Mediterranean diet, supplements and more.
Erectile Dysfuncation and Scleroderma is presented by
N. Bennett, MD, FACS
Associate Professor of Urology, Department of Urology, Northwestern University, Feinberg School of Medicine
Co-Director Andrology Fellowship
What Should I Eat includes information and answers to patient questions regarding diet, nutrition and scleroderma. It is presented by Bethany Doerfler, MS, RD, LDN
A patient's inspiring journey and practical tips that are applicable to everyone. Learn how to strengthen certain parts of your body as well as modify exercises to maintain physical health while coping with scleroderma.
Sleep is significantly disturbed for various reasons in chronic illnesses. Treating the sleep disturbance concomitantly with the underlying illness may lead to improved quality of life.
Sleep, depression and pain are interdependent symptoms. Hrayr Attarian, MD discusses sleep in chronic illnesses with a focus on scleroderma.
Benjamin Korman, MD discusses the genetics of scleroderma and the genomic era. Genetics and genomics are complicated, and getting more so every day. Every patient is genetically unique, but new technology will make it easier to understand individuals’ genetic susceptibility to disease and response to therapy.
Darren M. Brenner, MD, Assistant Professor of Medicine and Surgery at Northwestern University's Feinberg School of Medicine discusses fecal incontinence in scleroderma patients including its prevalence, diagnostics, types and therapeutics.
Benefits of Physical Therapy for Patients with Scleroderma is presented by
Jessica Mandac, PT, DPT
Rehabilitation Institute of Chicago
Center for Pain Management
The Rehabilitation Institute of Chicago's Karen Grube presents on the effects of Physical Therapy on Scleroderma. Find out what the current research tells us about PT and Scleroderma and what kind of problems PT can help.
Michael J. Cuttica MD, Assistant Professor of Medicine at the Northwestern Pulmonary Hypertension Program of Northwestern University discusses Pulmonary Arterial Hypertension in scleroderma patients, including how it is diagnosed and treated.
Skin Complications in Scleroderma
Emily L Keimig, MS, MD Clinical Instructor Department of Dermatology
Presented at the Scleroderma Patient Education Conference, Saturday, October 19, 2013 at Northwestern Memorial Hospital.
Hosted by the Scleroderma Foundation, Greater Chicago Chapter and the Northwestern Scleroderma Program.
Pulmonary Arterial Hypertension: The Other High Blood Pressure and its association with scleroderma is presented by
Micheal J. Cuttica MD, MS, Assistant Professor of Medicine, Director; Northwestern Pulmonary Hypertension Program, Northwestern University
Dr. Roberto Machado from the University of Illinois at Chicago presented an update on PAH at a Patient Education Conference on March 15, 2014 hosted by the Scleroderma Foundation, Greater Chicago Chapter.
The Role of Extracorporeal Photopheresis in Scleroderma is presented by
Jaehyuk Choi
Assistant Professor in the Department of Dermatology
Director of the Extracorporeal Photopherisis Unit
SCLERODERMA: Searching for the Cause and the Cure
Maureen D. Mayes, MD, MPH Professor of Medicine Director of the Scleroderma Program Division of Rheumatology University of Texas - Houston
Presented at the Scleroderma Patient Education Conference, Saturday, October 19, 2013 at Northwestern Memorial Hospital.
Hosted by the Scleroderma Foundation, Greater Chicago Chapter and the Northwestern Scleroderma Program.
Renal Denervation in Resistant Hypertension 23.pptxPrerna806536
Device based therapy for management of resistant hypertension includes many modalities, out of which Renal Artery denervation is very close to clinical application.
NIH Presentation Nov 2016 Neuroendocrine Tumor Clinical TrialsCACSNETS
NIH/NCI presentation provides an overview of and NIH clinical trials. Briefing covers: 1) Overview of GI and pancreatic Neuroendocrine Tumors (NETs) /Carcinoid Cancer;
2) Treatment options for patients with advanced GI and pancreatic NETs; 3) Clinical trials for/in patients with NETs
XIII Reunión anual de la sección de Insuficiencia Cardiaca de la SEC
OVIEDO, 16-18 JUNIO 2016 HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS (HUCA)
http://secardiologia.es/insuficiencia/cientifico/ic-oviedo-2016
Simposio: Abordaje integral y multidisciplinar de la Insuficiencia Mitral
VIERNES, 17 DE JUNIO 12:45-14:00 SALA A
Posibilidades del tratamiento percutáneo
Xavi Freixa Rofastes, Barcelona
Dr. John Frederik presents "CTSA Summit TAVR" at the March 4 -6, 2016 Cardiac and Thoracic Surgery Associates, Cardiovascular Summit at The Westin Riverfront Resort and Spa.
Similar to Fat Transfer to the Upper and Lower Extremities in Patients with Raynaud's Phenomenon - A Novel Therapeutic Modality (20)
This talk was presented by Michael Macklin, MD from the University of Chicago at the Scleroderma Patient Education Conference on May 4, 2024, hosted by the Scleroderma Foundation of Greater Chicago. This talk includes:
Overview of scleroderma manifestations, organ involvement, brief classifications (limited, diffuse, sine scleroderma)
Overview of current treatment options, need for additional therapies
Overview of plan for multi-disciplinary scleroderma center at the University of Chicago
Potential future therapies in the literature at large
Planned trials/future treatment options at the University of Chicago
For more info about scleroderma and the foundation, head to www.stopscleroderma.org
Interstitial lung disease (ILD) is a common complication of scleroderma that leads to inflammation and scarring of the lungs. In this session, we will review the prevalence of scleroderma-associated ILD (SSc-ILD), classic symptoms, and the approach to evaluating patients with suspected disease. In addition, we will cover various treatments available for patients with SSc-ILD.
This talk was presented at the Scleroderma Patient Education Conference on May 4, 2024, hosted by the Scleroderma Foundation of Greater Chicago.
For more info about scleroderma and the foundation, head to www.stopscleroderma.org
Overview of scleroderma manifestations, organ involvement, brief classifications (limited, diffuse, sine scleroderma). Overview of current treatment options, need for additional therapies. Overview of plan for multi-disciplinary scleroderma center at the University of Chicago. Potential future therapies in the literature at large. Planned trials/future treatment options at the University of Chicago.
For more info about scleroderma and the foundation, head to www.stopscleroderma.org
This talk was presented at the Scleroderma Patient Education Conference on May 4, 2024, hosted by the Scleroderma Foundation of Greater Chicago.
This session will discuss modalities and demonstrate exercises to improve movement and function in the hands, face and mouth. Suggestions will be also be provided on the use of assistive devices and alternate techniques to accomplish tasks of daily living to increase independence and protect the hands.
This presentation was held on May 4, 2024 by the Scleroderma Foundation of Greater Chicago.
For more information on the foundation and scleroderma, head to our website at www.stopscleroderma.org
Chronic pain is common. If we don’t suffer from it ourselves, chances are we know someone who does. Changes in the structure and function of the brain are thought to underlie chronic pain. The good news is that these changes are not hardwired. Many things can be done to influence how the brain processes pain signals including exercise, healthy eating, and better sleep, as well as thinking more adaptive thoughts, positive emotions, and feeling love and connected. This session will highlight the neuroscience related to chronic pain and how engaging in simple self-management strategies can result in less pain and a more rewarding life.
This presentation comes from the Spring Patient Education conference presented by the Scleroderma Patient Education Conference presented by the Scleroderma Foundation of Greater Chicago.
See the slides from the Scleroderma Foundation of Greater Chicago's Workshop: Improving Mental Health with Chronic Illness. This presentation was held by the mental health professionals at Ellie Mental Health.
Learn from Bethany Doerfler, MS, RD, LDN, a registered dietitian whose clinical practice and research focuses on providing wellness-based medical nutrition therapy for digestive disorders and allergic bowel diseases. She currently practices in the Division of Gastroenterology and Hepatology at Northwestern Medicine in Chicago, IL. She is the first dietitian to be fully integrated into a gastroenterology division for both research and patient care. This presentation is optimized for Scleroderma patients to learn about their diet options to improve scleroderma symptoms and their gut health.
This presentation covers gastrointestinal issues, which are commonly experienced by those living with scleroderma. This session is set to be an invaluable resource for patients and caregivers, as it will provide crucial insights and approaches to managing GI issues effectively. Dr. Khanna's vast knowledge and experience make this talk a must-attend event for anyone seeking to enhance their understanding and management of GI symptoms in scleroderma.
Dr. Richardson's presentation focuses on scleroderma's impact on the hands, particularly calcinosis. You can expect to gain valuable knowledge that will empower them in their journey with scleroderma. This talk promises to be an invaluable opportunity for patients to deepen their understanding of these conditions and enhance their approach to managing scleroderma-related symptoms.
This talk will center around the crucial topic of interstitial lung disease (ILD). Gain invaluable insights into the latest advancements in ILD management, potential treatment options, and the importance of clinical trials in advancing care for scleroderma patients.
Dr. Cuttica and Dr. Mylvaganam will co-lead an insightful talk on pulmonary hypertension (PH). Attendees will have the opportunity to learn about pulmonary hypertension, one of the most serious conditions that impact individuals with scleroderma. The talk will give an overview of pulmonary hypertension and potential treatment options.
In this talk we will discuss the most common findings associated with scleroderma. We will discuss some of the methods your dental team can utilize to help manage your condition, and also some ways that you can help yourself and your dental team manage your condition. We will discuss some unique methods for maintaining your oral health care and will conclude with an open Q&A session.
Virtually every aspect of systemic sclerosis can be beneficially impacted by exercise: inflammation, circulation, body warmth, GI, skin, musculoskeletal and lung health.
The therapeutic underpinnings of exercise target the specific mechanisms behind the pervasive SSc-disease biological, physical and psychological manifestations.
This session is intended to empower people living with scleroderma with knowledge of systemic sclerosis and the anticipated impact exercise and physical activity can have on the many manifestations of systemic sclerosis.
At the end of this session, attendees should have a better understanding of the extent of SSc and feel confident in constructing an exercise regimen generally and for their particular needs related to scleroderma.
This talk will review the best practices for monitoring for the early detection of interstitial lung disease (ILD) and pulmonary hypertension (PH), the two most common and serious lung diseases that occur in patients with scleroderma. It will also cover the many new medications approved for the treatment of ILD and PH and when these medications are indicated. The goal is for patients with scleroderma to understand the recent advances in the diagnosis and treatment of scleroderma-associated lung diseases that are leading to improved outcomes.
In this talk, Dr. Brown will expand your knowledge of how scleroderma impacts the GI tract. This presentation is crucial as an estimated 90% of scleroderma patients suffer from gastrointestinal complications.
Dr. Brown is well-known for his exceptional ability to make complex medical information easy to understand.
Presented by Murray Baron, MD at the Scleroderma Patient Education Conference, hosted by the Scleroderma Foundation Greater Chicago Chapter on Saturday, October 12, 2019 in Chicago, IL. For more about the foundation visit scleroderma.org/chicago.
Presented by Jennifer Mundt, PhD at the Scleroderma Patient Education Conference, hosted by the Scleroderma Foundation Greater Chicago Chapter on Saturday, October 12, 2019 in Chicago, IL.
Presented by Jane Dematte, MD at the Scleroderma Patient Education Conference hosted by the Scleroderma Foundation on Saturday, October 12, 2019 in Chicago, IL
Presented by Darren M. Brenner, MD at the Scleroderma Patient Education Conference hosted by the Scleroderma Foundation Greater Chicago Chapter on Saturday, October 12 in Chicago, IL.
More from Scleroderma Foundation of Greater Chicago (20)
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Fat Transfer to the Upper and Lower Extremities in Patients with Raynaud's Phenomenon - A Novel Therapeutic Modality
1. Fat Transfer to the Upper and Lower
Extremities
in Patients With Raynaud’s Phenomenon –
A Novel Therapeutic Modality
Jonathan Bank, MD, Sam A. Fuller, MD
Ginard I. Henry, MD, Lawrence S. Zachary, MD
Section of Plastic and Reconstructive Surgery
Department of SurgeryNo disclosures
2. Fat Transfer to the Upper and Lower
Extremities
in Patients With Raynaud’s Phenomenon –
A Novel Therapeutic Modality
Jonathan Bank, MD, Sam A. Fuller, MD
Ginard I. Henry, MD, Lawrence S. Zachary, MD
Section of Plastic and Reconstructive Surgery
Department of Surgery
5. 5Fat Transfer in Raynaud’s
Treatment
Ca Channel
Blockers
ARB
Protective
Measures PDE-I
Clopidogrel
Endothelin
Receptor
Blockers
Alpha
Blockers
Topical
Nitrates
ACE-I
ASA
Prostanoids
6. 6Fat Transfer in Raynaud’s
Treatment
Ca Channel
Blockers
ARB
Protective
Measures PDE-I
Clopidogrel
Endothelin
Receptor
Blockers
Alpha
Blockers
Topical
Nitrates
ACE-I
ASA
Prostanoids
Invasive
Modalities
Surgical
Sympathectomy
Neuro-
modulators
Fat Transfer
7. • Clinical improvement – radiation dermatitis, burns
• Histological evidence – Sultan, PRS 2011
– Radiation dermatitis murine model fat injection
– Regression of hyperpigmentation, ulcers and fibrosis
– Improvements in the inflammatory, microvascular,
and fibrotic characteristics
• Mechanism unclear –
Restoration of depleted adipose-derived stem cells?
7Fat Transfer in Raynaud’s
Fat Transfer Rationale
Raynaud’s - different pathogenesis – similar end effect
8. 8Fat Transfer in Raynaud’s
Goal
as a means to delay progression of
Raynaud’s Phenomenon
after failure of medical management
Utilize fat grafting
9. • Adaptation of rejuvenation of the hand by fat grafting
• Approximately 30 ml of decanted fat
• Abdominal depots
• Injected via blunt cannulae into the affected extremity
9Fat Transfer in Raynaud’s
Technique
10. 10Fat Transfer in Raynaud’s
Technique
10 ml - dorsum of hand
3 ml - snuff-box
2-3 ml - each dorsal webspace
6 ml - along palmar arch
1 ml - palmar webspaces 2-4
2 ml - first webspace
2 ml - ulnar border of small finger
12. 12
Results
Fat Transfer in Raynaud’s
Total patients 14
Total extremities 25
Hand 20
Feet 5
Mean follow up 12 months (4-17)
Female: Male 13:1
Primary: Secondary 8:6
Average fat injected 23.29 ml (10-30)
Concomitant digital sympathectomy 4
13. 13
Results
Overall improvement 92.5% of patients
Pain reduction 85.7% (7 2.6)
1 patient – no change
1 patient – increased pain
Cold attacks 78.5% decreased frequency
and severity
Ulcerations 66% improvement
Major complications 0
Minor complications 2
Subsequent neuromodulator 1
Subsequent sympathectomy 1
Fat Transfer in Raynaud’s
19. 19Fat Transfer in Raynaud’s
Hand Vascular Perfusion by Laser Doppler
Normal Moderate Severe
20. 20Fat Transfer in Raynaud’s
Hand Vascular Perfusion by Laser Doppler
21. 21Fat Transfer in Raynaud’s
Hand Vascular Perfusion by Laser Doppler
22. 22Fat Transfer in Raynaud’s
Preop Postop
200
150
100
50
Perfusionunits
Hand Vascular Perfusion by Laser Doppler
QMRADASH
23. Durable clinical improvement in the majority of treated patients
Safe, relatively straightforward
Mechanism – to be elucidated (stem cell angiogenesis? padding?)
Role in treatment of advanced, refractory Raynaud’s Phenomenon
23
Conclusions
Fat Transfer in Raynaud’s
Editor's Notes
Thank you for allowing me to present here today
The work I will discuss is really an innovation of larryzachary123
Raynaud’s phenomenon is a common affliction effecting 2% of the adult population, More commonly in womanIt results from an imbalance between vasodilation and vasoconstriction
It can be divided in to primary raynaud, which usually exists in isolation from systemic diseaseand in which the vasoconstriction results in cold attacks an pain, which can be severe and debilitatingSecondary raynauds typically occurs in the setting of autoimmune diseases such as systemic sclerosis (or scleroderma)And manifests in fibrosis, scarring, contractures, ulcerations and even autoamputationsClearly there is a continuum of disease manifestation
Initial treatment is preventative – with gloves and cold avoidanceBut many patients progress to require medical treatment with calcium channel blockers and topical nitratesAnd there is a whole host of other medications aimed at vasodilation and prevention of arterial thrombosis
Despite all of these options,A portion of these patients develop severe, refractory symptomsAnd this is where the hand surgeon comes in to play, invoking invasive modalities With injection of neuromodulators such as botulinum toxin – which has shown to be effective, but short lived, and can be an arduous undertaking for the patient and surgeon when done in the clinic settingAnother option would be surgical sympathectomy of the hands of affected feet – this is not a trivial undertaking, with inherent procedural risks, and requires somewhat specialized trainingand my not be long-lived with the regrowth of the stripped adventitiaThe intervention we propose he today is autologous fat grafting into the affected extremities
The rationale here stems from the clinical improvement witnessed in radiation dermatitis treated with fat injection, and to a certain extent in burn reconstructionA published study from a murine model shower regression of hyperpigmentation, ulcers and fibrosisWith histological correlatesHowever, the mechanism is unknown, and thought to be related to repletion of adipose derived stems cells into the injured tissueRecognizing that the pathophysiology in raynauds is differet, we contend that the end result at the tissue level is similar
We therefore set out to utilize fat graftingAs a means to treat patients with refractory cases of raynauds
We adapted a technique popularized by coleman for cosmetic rejuvenation of the hand by fat graftingAnd inject approximately 30 ccs of decanted fat from abdominal sources,Via blunt cannulae into the affcted extremity
The fat is dispersed subcutaneously and deeper, along the vessels as follows10 cc dorsum of the hand3 ml in the snuff box2-3 in each dorsal webspace6 cc along the palmar arch, the palmar webspaces and along the digital vessels
Here you can see the fat being injected while withdrawing the cannula
Over the past couple of years we performed this procedure on 14 patientsOr 25 extremitiesMainly in the handsWith a mean follow up of one yearMost of the patients severe females with primary raynaudsThe average amount of fat was about 23 ccAnd four had concomitant single digit sympathectomy for critical ischemia
All in all – We some some levelof improvement in the vast majority of our patientsPrimary in pain reliefAlthou one patient reported no changeAnd would stated her pain was actually worseIn the patients that had ulcerations – two thirds were much improved or healedTwo patients required further interventions at a 3-6 month interval
It may be difficult to appreciate the subtle coloration improvement in this case
But here you can clearly see the healing of several ulcers In the patient with severe scleroderma
With overall improvement suggested by here wearing her ring again
An example of fat transfer to the feet
We attempted to further quantify and monitor this intervention With speckle laser doppler that gives an idea as to the perfusion to the studied area
And this is an example of a clinically improved patient with a correlating improvement in measured perfusion
However, not all of our outcomes were as encouraging
We really had a range of measured responses that did not directly correlate with our clinical obserationsAnd we are are still working out how to utilize this technologyAnd are in the process of using other objective measure sucha s the DASH score whch grades functionAs well as quantitative MRA for a better assessment of tissue perfusion and longevity of the far grafts5 showed LD improvement – 4/5 improved clinically, but the impovement was not sig in the LD5 LD decrease – 4/5 improved symptoms
In conclusion we found fat transfer in patients with raynauds phenomenon of varying degrees Provides a durable clinical improvement in the majority of treated patientsIt appears to be safe and relatively straightforwardThe precise mechanism has yet to be elucidated – and perhaps has to do with neoangiogenesis and decreased scar promoted by stem cellsAlthough I think in the scleroderma patients – even the small amount of fat that survives, Provides a little bit of padding and cushioning to their severely sclerotic digitsSo we think that there is definitely a role for fat transfer in advanced, refractory raynauds phenomenonAnd look forward to collaborating with other surgeons on this project